Market Movers

Intuitive Surgical, Inc.’s Stock Price Soars to $580.11, Marking a Stellar 7.65% Increase

By January 16, 2025 No Comments

Intuitive Surgical, Inc. (ISRG)

580.11 USD +41.23 (+7.65%) Volume: 3.54M

Intuitive Surgical, Inc.’s stock price soared to 580.11 USD, marking a significant trading session increase of +7.65%, driven by a robust trading volume of 3.54M. With a year-to-date percentage change of +11.14%, ISRG’s stock continues to display strong performance, solidifying its position as a compelling investment opportunity.


Latest developments on Intuitive Surgical, Inc.

Intuitive Surgical, Inc. stock price surged today after beating Q4 estimates and announcing record revenue growth of 25% to $2.41 billion. The company’s strong performance in 2024, along with an optimistic outlook for 2025, has attracted the attention of investors. This positive news led to Intuitive Surgical stock hitting a 52-week high of $562 and reaching an all-time high. Various financial institutions, including Brendel Financial Advisors LLC and Assenagon Asset Management S.A., have increased their stakes in the company, further boosting investor confidence. With demand for robot surgery on the rise, Intuitive Surgical, Inc. (NASDAQ:ISRG) continues to be a top choice for those looking to invest with confidence.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars